Trial intelligence / Profile preview

Maxigesic IV vs Acetaminophen in C-Section

NCT06479122Phase 4Recruiting

Sponsor
Seoul National University Hospital
Start
Oct 2024
Primary completion
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of Combogesic IV in postoperative pain (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Obstetric Quality of Recovery-11K Score at 24 hours. Started Oct 2024; status: recruiting.

02

Drugs

Combogesic IV
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06479122.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06479122.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call